Actively Recruiting
Extended One-level Interbody Fusion for Adjacent Vacuum Phenomenon in Lumbar Degenerative Disc Disease
Led by Xuanwu Hospital, Beijing · Updated on 2023-09-08
126
Participants Needed
1
Research Sites
308 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective of this study was to validate the clinical effectiveness of interbody fusion with a one-segment extension for the treatment of adjacent segmental space discs in the surgical treatment of lumbar degeneration.
CONDITIONS
Official Title
Extended One-level Interbody Fusion for Adjacent Vacuum Phenomenon in Lumbar Degenerative Disc Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 60 years old
- Lumbar degeneration requiring 1-2 segment interbody fusion
- Vacuum signs in adjacent discs without symptoms or instability (power position slip 3mm and segmental angle change 106)
- Agreement with surgical plan and willingness for long-term follow-up
- Signed informed consent form
You will not qualify if you...
- Drug or alcohol abuse
- Abnormal liver or kidney function unsuitable for surgery
- Cardiac insufficiency unsuitable for surgery
- Severe metabolic or endocrine diseases unsuitable for surgery
- Severe lung disorders such as asthma or abnormal lung function unsuitable for surgery
- Pregnant, breastfeeding, or planning pregnancy soon
- Participation in other clinical trials within 3 months
- Considered unsuitable for the study by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Actively Recruiting
Research Team
H
Hao Wu, MD,PhD
CONTACT
F
Fengzeng Jian, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here